MedPath
NMPA Approval

Theophylline Sustained-release Tablets

国药准字H44020002

April 9, 2024

Drug Information

茶碱缓释片

白云山

片剂(缓释)

0.1g

化学药品

April 9, 2024

Company Information

Applicant Company

广州市海珠区南石路1号

Manufacturing Company

广州市海珠区南石路1号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

茶碱缓释片 - NMPA 批准文号 | MedPath